ANTIMICROBIAL PEPTIDES AND MODIFICATIONS THEREOF
Antimicrobial modified defensin or defensin-like peptides, modified C-terminal fragments of a defensin or defensin-like peptides and nucleic acids encoding the same are disclosed. Compositions comprising the defensin variant peptides and methods of their use to control microbial infections of plants and vertebrate subjects as well as contamination of feedstuffs and foodstuffs are also disclosed.
1 .- 28 . (canceled)
29 . A recombinant polynucleotide encoding a peptide comprising: (i) a defensin or defensin-like peptide comprising a wild-type gamma-core consensus peptide GXCX 3-9 C, GXCX 9-16 C or GXCX 3-22 C, optionally wherein the defensin or defensin-like peptide comprises SEQ ID NO: 560, 573, 620, 633, 645, 715, 723, or a variant thereof having at least 85% sequence identity to SEQ ID NO: 560, 573, 620, 633, 645, 715, a variant thereof comprising a deletion of 1 to 10 N-terminal amino acid residues, a deletion of 1 to 10 C-terminal amino acid residues, and/or a variant thereof having a conservative amino acid substitution of 1 to 10 amino acid residues; wherein the polynucleotide encoding the peptide is operably linked to a polynucleotide comprising a promoter which is heterologous to the polynucleotide encoding the peptide.
30 . The recombinant polynucleotide of claim 29 , wherein the recombinant polynucleotide further comprises a polynucleotide encoding: (i) a transit peptide, a vacuolar targeting peptide, and/or an endoplasmic reticulum targeting peptide; (ii) a plastid targeting peptide; and/or (iii) a polyadenylation or transcriptional termination signal, wherein the polynucleotides of (i), (ii), and/or (iii) are operably linked to the polynucleotide encoding the antimicrobial peptide.
31 . The recombinant polynucleotide of claim 29 , wherein the polynucleotide encoding the peptide is inserted into a heterologous nuclear or plastid genome of a cell and operably linked to an endogenous promoter located in the heterologous nuclear or plastid genome.
32 . (canceled)
33 . A cell comprising the recombinant polynucleotide of claim 29 , wherein the cell is optionally a bacterial, yeast, or plant cell.
34 . A plant comprising the recombinant polynucleotide of claim 29 .
35 . A plant part of the plant of claim 34 , wherein the plant part comprises the recombinant polynucleotide, optionally wherein the plant part is a seed, stem, leaf, root, tuber, flower, vegetable, or fruit.
36 . (canceled)
37 . A method for producing an antifungal peptide comprising: (i) culturing the cell of claim 33 under conditions wherein the peptide, defensin, or defensin-like peptide is expressed by the cell; and (ii) purifying the peptide, defensin peptide, or defensin-like peptide from the culture.
38 . The method of claim 37 , wherein the cell is a yeast cell, optionally wherein the recombinant polynucleotide comprises a polynucleotide encoding a transit peptide which is operably linked to the polynucleotide encoding the peptide, defensin peptide, or defensin-like peptide and optionally wherein the peptide, defensin peptide, or defensin-like peptide is purified from the culture supernatant.
39 . The method of claim 38 , wherein the yeast cell is a Candida, Kluveromyces, Hansuela, Pichia, Saccharomyces, Schizosaccharomyces , or Yarrowia cell.
40 .- 45 . (canceled)